Itai Benhar

This inventor holds 18 USPTO granted patents and 3 published patent applications and 3 EPO patents, primarily in Targeted Therapeutics. Top assignees: Tel Aviv University, Technion Research & Development Foundation Ltd, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Itai Benhar. Retrieved from https://idiyas.com/inventor/itai-benhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 33.3

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 20(Granted Patents)

Location History:

Rehovat, IL (2012)
Rechovot, IL (2011 - 2015)
Rehovot, IL (2011 - 2023)

Company Filing History:

Technion Research & Development Foundation Ltd

patents

1 out of 60

The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Anti-Ide Antibodies

Modular Platform

Targeted Therapeutics

Monospecific Antibodies

Activatable Toxin Complexes

Photocatalytic Hydrogen Production

Recombinant Fusion Proteins

Immunotoxin Production

Human Synthetic Antibodies

Bacteriophages

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698344 - ANTI-IDE ANTIBODIES AND USES OF SAME (2026-08-04),

2. 12668643 - MODULAR PLATFORM FOR TARGETED THERAPEUTICS (2026-06-30),

3. 12509512 - SEMAPHORIN 3A ANTIBODIES AND USES THEREOF (2025-12-30),

4. 11708421 - Modular platform for targeted therapeutics (2023-07-25),

5. 10822428 - Bi-and monospecific, asymmetric antibodies and methods of generating the same (2020-11-03),

6. 9925275 - Amphotericin B derivatives (2018-03-27),

7. 9750817 - Amphotericin B derivatives (2017-09-05),

8. 9624291 - Bi- and monospecific, asymmetric antibodies and methods of generating the same (2017-04-18),

9. 9321847 - Activatable toxin complexes comprising a cleavable inhibitory peptide (2016-04-26),

10. 9181555 - Photocatalytic hydrogen production and polypeptides capable of same (2015-11-10),

11. 8741598 - Photocatalytic hydrogen production in cyanobacteria (2014-06-03),

12. 8597655 - Recombinant fusion protein and polynucleotide construct for immunotoxin production (2013-12-03),

13. 8563294 - Photocatalytic hydrogen production in cyanobacteria (2013-10-22),

14. 8329183 - Recombinant fusion protein and polynucleotide construct for immunotoxin production (2012-12-11),

15. 8207309 - Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses (2012-06-26),

Title: The Innovative Mind of Itai Benhar

Introduction: Itai Benhar, a talented inventor hailing from Rehovot, Israel, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Itai Benhar's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including telecommunications, renewable energy, and healthcare.

Career Highlights: With a career spanning over two decades, Itai Benhar has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the industry.

Collaborations: Itai Benhar has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, Itai Benhar's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.